John Trizzino
President at NOVAVAX, INC.
Net worth: 110 489 $ as of 2024-04-29
Network origin in John Trizzino first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 60 | |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
41
| Subsidiary | Biotechnology | 41 |
ID Biomedical Corp.
 ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.
14
| Subsidiary | Medical Specialties | 14 |
| Public Company | Medical Distributors | 13 | |
3
| Public Company | Biotechnology | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to John Trizzino via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| The Johns Hopkins University | College/University | Graduate Degree Undergraduate Degree Director/Board Member Director/Board Member Graduate Degree Doctorate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing General Counsel Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| GENVEC INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Chairman | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Director of Finance/CFO Chief Operating Officer Director/Board Member | |
| Lehigh University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Chairman Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Investment Managers | President Founder President | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
| AETNA | Managed Health Care | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| CRH MEDICAL CORPORATION | Medical/Nursing Services | Chairman Director/Board Member Corporate Secretary | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Dartmouth College | College/University | Director/Board Member Undergraduate Degree Undergraduate Degree | |
| University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Operating Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ARDELYX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Operating Officer | |
| MAXCYTE, INC. | Biotechnology | Director/Board Member Chairman Corporate Officer/Principal | |
| US Department of Health & Human Services (DC) | General Government | Corporate Secretary Corporate Officer/Principal President | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman | |
| West Virginia University | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Chairman Corporate Officer/Principal Founder | |
Micro Bio Medics, Inc.
 Micro Bio Medics, Inc. Medical DistributorsDistribution Services Part of Henry Schein, Inc., Micro Bio Medics, Inc. is a private company that distributes medical, dental, and hospital equipment. The company is based in Pelham Manor, NY. The company was founded by Michael John Brooke. Micro Bio Medics was acquired by Henry Schein, Inc. on August 01, 1997 for $72.48 million. | Medical Distributors | Corporate Officer/Principal Director of Finance/CFO President | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member | |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Sales & Marketing President | |
Biohealth Innovation, Inc.
 Biohealth Innovation, Inc. Financial ConglomeratesFinance Biohealth Innovation, Inc. sources and evaluates market-relevant bioheath intellectual properties, connects the IP with funding, and assists businesses in marketing and growth. It is a regional innovation intermediary that accelerates and facilitates technology transfer and commercialization of market-relevant research in federal labs, universities, and biohealth companies in the Region. The company was founded in 2011 and is headquartered in Rockville, MD. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Chief Operating Officer Director/Board Member | |
| Caligor Medical & Office Supply Co. | Corporate Officer/Principal President | ||
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| ONCOLYTICS BIOTECH INC. | Biotechnology | Director/Board Member Chairman | |
| Brown University | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Iowa | College/University | Graduate Degree Undergraduate Degree | |
| University of Calgary | College/University | President Doctorate Degree | |
| Villanova University | College/University | Undergraduate Degree Undergraduate Degree | |
| PROGRESSIVE CORPORATION | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRII BIOSCIENCES LIMITED | Miscellaneous Commercial Services | Director/Board Member Chief Tech/Sci/R&D Officer | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
| State University of New York at Buffalo | College/University | Undergraduate Degree Masters Business Admin |
Statistics
International
| United States | 44 |
| United Kingdom | 4 |
| Canada | 4 |
| China | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 16 |
| Finance | 6 |
| Health Services | 3 |
| Commercial Services | 3 |
Operational
| Director/Board Member | 474 |
| Corporate Officer/Principal | 219 |
| Independent Dir/Board Member | 126 |
| Chairman | 122 |
| President | 98 |
Most connected contacts
| Insiders | |
|---|---|
| David Mott | 45 |
| James Cavanaugh | 38 |
| Norman Matthews | 35 |
| Peter Greenleaf | 31 |
| Rajiv Indravadan Modi | 31 |
| Louis Sullivan | 31 |
| Gail Boudreaux | 30 |
| David Baltimore | 27 |
| Gary Evans | 25 |
| Sven Arne Andréasson | 24 |
| George Milne | 24 |
| Barbara Hackman Franklin | 22 |
| Philip Laskaway | 22 |
| Todd R. Patrick | 22 |
| Wayne T. Hockmeyer | 22 |
- Stock Market
- Insiders
- John Trizzino
- Company connections